SBIR/STTR Research Award
Quantitative Analysis of Cancer-associated EVs
Award amount
$2,000,000Program and phase
SBIR · Phase IIAward year
2023Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Cellarcus Biosciences, Inc.
- Proposal award date
- 2023-06-09
- Contract end date
- 2025-05-31
- UEI
- QUVQAKJFJCQ9
- Solicitation number
- PA21-259
- Topic code
- 102
Research abstract
Abstract All cells in the body, including tumor cells, release small vesicles that can be found in blood, cerebrospinal fluid, and even urine. Because each vesicle was released by a specific cell, their analysis can tell us about the cells from which they came, including whether that cell was infected, cancerous, or malfunctioning in some way. We will develop assays and kits to enable cancer researchers to analyze these vesicles to improve the ability to understand, detect and treat cancer.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Assays and kits for MSC-derived extracellular vesicles
- Identification of Cell Type-specific EVs for Neuroscience Research
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- MiREA, a mHealth intervention to Reduce Health Disparities by Improving Equitable Access to Mandated College Students with Problematic Alcohol and Marijuana Use
- Modex, a cloud-based, centralized health economic model marketplace to reduce costs and enhance equity in cancer
- Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas
- Allogeneic cell and gene therapy for neuroendocrine tumors
- Nanoparticle formulation of Mediator kinase inhibitor for the treatment of peritoneal ovarian cancer
Research funding history
3 SBIR/STTR records share this UEI (2019–2023). Reported award amounts total $5,089,417. Reported amounts are not federal obligations.
Phases: Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services